189295
Loading viewer...
investor_presentation
Format: PDF investor_presentation
This investor presentation by AIM ImmunoTech outlines forward-looking statements regarding Ampligen® and its potential in treating various diseases as of Q1 2023.
Loading viewer...
investor_presentation
Format: PDF investor_presentation
This investor presentation by AIM ImmunoTech outlines forward-looking statements regarding Ampligen® and its potential in treating various diseases as of Q1 2023.
presentation
investor_presentation
41 Pages
Timken Company
John Bean Technologies Investor Presentation — July 2022
investor_presentationinvestor_presentation
24 Pages
John Bean Technologies Corporation
